Investigation of Thiocarbamates as Potential Inhibitors of the SARS-CoV-2 Mpro
In the present study we tested, using the microscale thermophoresis technique, a small library of thionocarbamates, thiolocarbamates, sulfide and disulfide as potential lead compounds for SARS-CoV-2 Mpro drug design. The successfully identified binder is a representative of the thionocarbamates grou...
| Published in: | Pharmaceuticals |
|---|---|
| Main Authors: | Katarzyna Papaj, Patrycja Spychalska, Katarzyna Hopko, Patryk Kapica, Andre Fisher, Markus A. Lill, Weronika Bagrowska, Jakub Nowak, Katarzyna Szleper, Martin Smieško, Anna Kasprzycka, Artur Góra |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-11-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/14/11/1153 |
Similar Items
Evaluation of metallothionein response in Lymnaea stagnalis pond snail to exposured to trace metals and thiocarbamate fungicide
by: L. L. Gnatyshyna
Published: (2019-06-01)
by: L. L. Gnatyshyna
Published: (2019-06-01)
Evaluation of Xa inhibitors as potential inhibitors of the SARS-CoV-2 Mpro protease
by: Katarzyna Papaj, et al.
Published: (2022-01-01)
by: Katarzyna Papaj, et al.
Published: (2022-01-01)
Novel Cholinesterase Inhibitors Based on O-Aromatic N,N-Disubstituted Carbamates and Thiocarbamates
by: Martin Krátký, et al.
Published: (2016-02-01)
by: Martin Krátký, et al.
Published: (2016-02-01)
Enantiopure (S)-butan-2-yl N-(4-x-phenyl)thiocarbamates, x = NO2, OCH3, F, and Cl
by: Werner Kaminsky, et al.
Published: (2023-04-01)
by: Werner Kaminsky, et al.
Published: (2023-04-01)
Coordination of <i>O</i>-Propyl-<i>N</i>-phenylthiocarbamate to HgI<sub>2</sub> and the Crystallographic Characterization of an Anilinium Chloride Thiocarbamate Adduct
by: Wafa Arar, et al.
Published: (2024-11-01)
by: Wafa Arar, et al.
Published: (2024-11-01)
Advances in the Development of SARS-CoV-2 Mpro Inhibitors
by: Laura Agost-Beltrán, et al.
Published: (2022-04-01)
by: Laura Agost-Beltrán, et al.
Published: (2022-04-01)
Identification of broad-spectrum Mpro inhibitors: a focus on high-risk coronaviruses and conserved interactions
by: Man Liu, et al.
Published: (2025-12-01)
by: Man Liu, et al.
Published: (2025-12-01)
Inhibition of SARS-CoV-2 Mpro with Vitamin C, L-Arginine and a Vitamin C/L-Arginine Combination
by: Ivana Đukić, et al.
Published: (2023-01-01)
by: Ivana Đukić, et al.
Published: (2023-01-01)
Crystal structure of 4-{[(cyanoimino)(methylsulfanyl)methyl]amino}-1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one
by: Galal H. Elgemeie, et al.
Published: (2015-01-01)
by: Galal H. Elgemeie, et al.
Published: (2015-01-01)
Natural phenolic compounds from Satureja L. as inhibitors of COVID-19 protease (Mpro): Computational investigations
by: Faika Başoğlu-Ünal, et al.
Published: (2022-01-01)
by: Faika Başoğlu-Ünal, et al.
Published: (2022-01-01)
Investigating the Interaction of Herbal Medicinal Compounds Against Mpro Protease in SARS-CoV-2 Virus Strains
by: Roya Fallah Pour, et al.
Published: (2024-12-01)
by: Roya Fallah Pour, et al.
Published: (2024-12-01)
Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?
by: Matteo Pavan, et al.
Published: (2022-12-01)
by: Matteo Pavan, et al.
Published: (2022-12-01)
Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms
by: Julia M Flynn, et al.
Published: (2022-06-01)
by: Julia M Flynn, et al.
Published: (2022-06-01)
Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?
by: Srijan Chatterjee, et al.
Published: (2023-06-01)
by: Srijan Chatterjee, et al.
Published: (2023-06-01)
2,3,4,6-Tetra-O-acetyl-1-[(dimethylcarbamothioyl)sulfanyl]-β-d-galactopyranose
by: Reham A. Mohamed-Ezzat, et al.
Published: (2025-06-01)
by: Reham A. Mohamed-Ezzat, et al.
Published: (2025-06-01)
N-(4-Bromophenyl)methoxycarbothioamide
by: Chien Ing Yeo, et al.
Published: (2018-08-01)
by: Chien Ing Yeo, et al.
Published: (2018-08-01)
O-Methyl m-Tolylcarbamothioate
by: Chien Ing Yeo, et al.
Published: (2018-09-01)
by: Chien Ing Yeo, et al.
Published: (2018-09-01)
Evolutionary Structure Optimization of Ensitrelvir as Non-Covalent Inhibitor of SARS-CoV-2 Main Protease Mpro
by: Kateryna Lohachova, et al.
Published: (2024-09-01)
by: Kateryna Lohachova, et al.
Published: (2024-09-01)
Computational evaluation and benchmark study of 342 crystallographic holo-structures of SARS-CoV-2 Mpro enzyme
by: Hamlet Khachatryan, et al.
Published: (2024-06-01)
by: Hamlet Khachatryan, et al.
Published: (2024-06-01)
Uji Aktivitas Senyawa Bahan Alam terhadap Enzim Mpro pada SARS-CoV-2 Secara In Silico
by: Syahrul Hidayat, et al.
Published: (2021-12-01)
by: Syahrul Hidayat, et al.
Published: (2021-12-01)
Essential oils as an effective alternative for the treatment of COVID-19: Molecular interaction analysis of protease (Mpro) with pharmacokinetics and toxicological properties
by: Sukanya Panikar, et al.
Published: (2021-05-01)
by: Sukanya Panikar, et al.
Published: (2021-05-01)
Transient binding sites at the surface of haloalkane dehalogenase LinB as locations for fine-tuning enzymatic activity.
by: Agata Raczyńska, et al.
Published: (2023-01-01)
by: Agata Raczyńska, et al.
Published: (2023-01-01)
Transient binding sites at the surface of haloalkane dehalogenase LinB as locations for fine-tuning enzymatic activity
by: Agata Raczyńska, et al.
Published: (2023-01-01)
by: Agata Raczyńska, et al.
Published: (2023-01-01)
Unbinding ligands from SARS-CoV-2 Mpro via umbrella sampling simulations
by: Nguyen Minh Tam, et al.
Published: (2022-01-01)
by: Nguyen Minh Tam, et al.
Published: (2022-01-01)
Computational and in vitro evaluation of sumac-derived ©Rutan compounds towards Sars-CoV-2 Mpro inhibition
by: Muzaffar Kayumov, et al.
Published: (2025-02-01)
by: Muzaffar Kayumov, et al.
Published: (2025-02-01)
Discovery and evaluation of active compounds from Xuanfei Baidu formula against COVID-19 via SARS-CoV-2 Mpro
by: Min Zhang, et al.
Published: (2023-08-01)
by: Min Zhang, et al.
Published: (2023-08-01)
Bis(μ-iodo)-tetrakis(<i>O</i>-methyl <i>N</i>-phenylthiocarbamate)-tetraiodo-dibismuth
by: Wafa Arar, et al.
Published: (2022-06-01)
by: Wafa Arar, et al.
Published: (2022-06-01)
The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study
by: Mateus Sá Magalhães Serafim, et al.
Published: (2023-07-01)
by: Mateus Sá Magalhães Serafim, et al.
Published: (2023-07-01)
Coagulation modifiers targeting SARS-CoV-2 main protease Mpro for COVID-19 treatment: an in silico approach
by: Ísis Venturi Biembengut, et al.
by: Ísis Venturi Biembengut, et al.
Synthesis and evaluation of carmofur analogs as antiproliferative agents, inhibitors to the main protease (Mpro) of SARS-CoV-2, and membrane rupture-inducing agents
by: Tiffany Gu, et al.
Published: (2025-04-01)
by: Tiffany Gu, et al.
Published: (2025-04-01)
A potential allosteric inhibitor of SARS-CoV-2 main protease (Mpro) identified through metastable state analysis
by: Asma Fatima, et al.
Published: (2024-09-01)
by: Asma Fatima, et al.
Published: (2024-09-01)
Identification of natural compounds (proanthocyanidin and rhapontin) as high-affinity inhibitors of SARS-CoV-2 Mpro and PLpro using computational strategies
by: Mohamed F. AlAjmi, et al.
Published: (2021-03-01)
by: Mohamed F. AlAjmi, et al.
Published: (2021-03-01)
Genetic Surveillance of SARS-CoV-2 Mpro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid
by: Jonathan T. Lee, et al.
Published: (2022-08-01)
by: Jonathan T. Lee, et al.
Published: (2022-08-01)
Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus Agents
by: Agnieszka Zagórska, et al.
Published: (2024-07-01)
by: Agnieszka Zagórska, et al.
Published: (2024-07-01)
Protegrin-2, a potential inhibitor for targeting SARS-CoV-2 main protease Mpro
by: Zainab Jan, et al.
Published: (2023-01-01)
by: Zainab Jan, et al.
Published: (2023-01-01)
Identification of potential COVID-19 Mpro inhibitors through covalent drug docking, molecular dynamics simulation, and MMGBSA calculation
by: Mohammad Hossein Haghir Ebrahim Abadi, et al.
Published: (2025-07-01)
by: Mohammad Hossein Haghir Ebrahim Abadi, et al.
Published: (2025-07-01)
Natural Compounds Activities against SARS-CoV-2 Mpro through Bioinformatics Approaches for Development of Antivirus Candidates
by: Taufik Muhammad Fakih
Published: (2021-07-01)
by: Taufik Muhammad Fakih
Published: (2021-07-01)
[(Z)-N-(3-Fluorophenyl)-O-methylthiocarbamato-κS](triphenylphosphane-κP)gold(I): crystal structure, Hirshfeld surface analysis and computational study
by: Chien Ing Yeo, et al.
Published: (2020-08-01)
by: Chien Ing Yeo, et al.
Published: (2020-08-01)
Vertical migration of some herbicides through undisturbed and homogenized soil columns
by: Md. Wasim Aktar, et al.
Published: (2008-12-01)
by: Md. Wasim Aktar, et al.
Published: (2008-12-01)
Vertical migration of some herbicides through undisturbed and homogenized soil columns
by: Md. Wasim Aktar, et al.
Published: (2009-01-01)
by: Md. Wasim Aktar, et al.
Published: (2009-01-01)
Similar Items
-
Evaluation of metallothionein response in Lymnaea stagnalis pond snail to exposured to trace metals and thiocarbamate fungicide
by: L. L. Gnatyshyna
Published: (2019-06-01) -
Evaluation of Xa inhibitors as potential inhibitors of the SARS-CoV-2 Mpro protease
by: Katarzyna Papaj, et al.
Published: (2022-01-01) -
Novel Cholinesterase Inhibitors Based on O-Aromatic N,N-Disubstituted Carbamates and Thiocarbamates
by: Martin Krátký, et al.
Published: (2016-02-01) -
Enantiopure (S)-butan-2-yl N-(4-x-phenyl)thiocarbamates, x = NO2, OCH3, F, and Cl
by: Werner Kaminsky, et al.
Published: (2023-04-01) -
Coordination of <i>O</i>-Propyl-<i>N</i>-phenylthiocarbamate to HgI<sub>2</sub> and the Crystallographic Characterization of an Anilinium Chloride Thiocarbamate Adduct
by: Wafa Arar, et al.
Published: (2024-11-01)
